Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Trovagene Inc (TROV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014320
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests that provide important clinical information about mutations associated with common solid tumor cancers such as colorectal, melanoma, pancreas and lung cancer. These tests are used by physicians, third party clinical laboratories and pharmaceutical companies. Trovagene uses its proprietary Precision Cancer Monitoring (PCM) technology to detect and monitor circulating tumor DNA (ctDNA) in urine and blood for the detection and quantitation of oncogene mutations and improvement in cancer care. Trovagene is headquartered in San Diego, California, the US.

Trovagene Inc (TROV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Trovagene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Trovagene Inc, Medical Devices Deals, 2011 to YTD 2017 9
Trovagene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Trovagene Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 11
Licensing Agreements 13
Trovagene Enters into Licensing Agreement with Nerviano Medical Sciences for PCM-075 13
Trovagene Enters Into Licensing Agreement With Duke University And Duke University Health Systems For NPM1 Marker 14
Trovagene Enters Into Licensing Agreement With Genoptix For NPM1 Marker 15
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 16
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 17
Trovagene Inc – Key Competitors 18
Trovagene Inc – Key Employees 19
Trovagene Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Nov 09, 2017: Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results 21
May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 23
Corporate Communications 25
Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis 25
Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 26
Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Trovagene Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Trovagene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Trovagene Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Trovagene Inc, Medical Devices Deals, 2011 to YTD 2017 9
Trovagene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 11
Trovagene Enters into Licensing Agreement with Nerviano Medical Sciences for PCM-075 13
Trovagene Enters Into Licensing Agreement With Duke University And Duke University Health Systems For NPM1 Marker 14
Trovagene Enters Into Licensing Agreement With Genoptix For NPM1 Marker 15
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 16
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 17
Trovagene Inc, Key Competitors 18
Trovagene Inc, Key Employees 19
Trovagene Inc, Subsidiaries 20

★海外企業調査レポート[Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cenovus Energy Inc (CVE)-石油・ガス分野:企業M&A・提携分析
    Summary Cenovus Energy Inc (Cenovus Energy) is an oil and gas company, which explores, develops and produces crude oil and natural gas. The company also carries out processing of natural gas liquids. Cenovus Energy produces natural gas and oil through conventional and oil sands reserves. Its project …
  • C&S Wholesale Grocers, Inc.
    C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Shenzhen Topray Solar Co Ltd (002218):企業の財務・戦略的SWOT分析
    Shenzhen Topray Solar Co Ltd (002218) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Stolt-Nielsen Ltd (SNI):石油・ガス:M&Aディール及び事業提携情報
    Summary Stolt-Nielsen Ltd (Stolt-Nielsen) is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company operates a fleet of deep-sea, regional, coastal and inland parcel tankers, to offers transportation services to the manu …
  • John Menzies Plc:企業の戦略・SWOT・財務分析
    John Menzies Plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Storm Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Storm Therapeutics Ltd (Storm Therapeutics) a spin-out of University of Cambridge is focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer and other diseases. The company is engaged in modulating RNA modifying enzymes and is developing a unique …
  • The AES Corporation:発電所・企業SWOT分析
    The AES Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • NPC Co., Ltd.:企業の戦略・SWOT・財務情報
    NPC Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary NPC Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • TWC Enterprises Limited:企業の戦略・SWOT・財務情報
    TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Crisil Ltd (CRISIL):企業の財務・戦略的SWOT分析
    Summary Crisil Ltd (Crisil), a subsidiary of S&P Global Inc is a financial service provider that offers risk management services. The company provides ratings, research and risk and policy advisory services. It offers services such as credit ratings, business school gradings, real estate star rating …
  • Butterfield Private Banking:企業の戦略・SWOT・財務情報
    Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report Summary Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Almac Group Ltd:企業のM&A・事業提携・投資動向
    Almac Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Almac Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • ION Geophysical Corp (IO):企業の財務・戦略的SWOT分析
    ION Geophysical Corp (IO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Energir LP:企業の戦略的SWOT分析
    Energir LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Impresa Pizzarotti & C. S.p.A.:企業の戦略・SWOT・財務情報
    Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Impresa Pizzarotti & C. S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sunac China Holdings Ltd:戦略・SWOT・企業財務分析
    Sunac China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Sunac China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Karolinska Development AB (KDEV):製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • New China Life Insurance Company Ltd.:戦略・SWOT・企業財務分析
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Oi S.A. (OIBR4):企業の財務・戦略的SWOT分析
    Oi S.A. (OIBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆